TCW Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.85M | Sell |
25,147
-68,512
| -73% | -$24.4M | 0.07% | 140 |
|
|
2025
Q4 | $30.7M | Sell |
93,659
-56,396
| -38% | -$17.9M | 0.22% | 91 |
|
|
2025
Q3 | $42.3M | Sell |
150,055
-42,771
| -22% | -$12.4M | 0.35% | 69 |
|
|
2025
Q2 | $53.8M | Sell |
192,826
-28,918
| -13% | -$8.19M | 0.42% | 65 |
|
|
2025
Q1 | $69.1M | Sell |
221,744
-1,018
| -0.5% | -$301K | 0.62% | 47 |
|
|
2024
Q4 | $58.1M | Sell |
222,762
-53,965
| -20% | -$16M | 0.49% | 61 |
|
|
2024
Q3 | $89.2M | Buy |
276,727
+16,984
| +7% | +$5.56M | 0.78% | 36 |
|
|
2024
Q2 | $81.2M | Buy |
259,743
+60,542
| +30% | +$17.8M | 0.73% | 38 |
|
|
2024
Q1 | $56.6M | Buy |
199,201
+24,310
| +14% | +$7.11M | 0.57% | 50 |
|
|
2023
Q4 | $50.4M | Buy |
174,891
+35,040
| +25% | +$9.55M | 0.56% | 50 |
|
|
2023
Q3 | $37.6M | Sell |
139,851
-22,774
| -14% | -$5.68M | 0.47% | 60 |
|
|
2023
Q2 | $36.1M | Buy |
162,625
+12,294
| +8% | +$2.85M | 0.4% | 68 |
|
|
2023
Q1 | $36.3M | Buy |
150,331
+8,321
| +6% | +$2.04M | 0.46% | 62 |
|
|
2022
Q4 | $37.3M | Buy |
142,010
+11,585
| +9% | +$3.11M | 0.53% | 57 |
|
|
2022
Q3 | $29.4M | Buy |
130,425
+16,049
| +14% | +$3.89M | 0.43% | 59 |
|
|
2022
Q2 | $27.8M | Buy |
114,376
+54,015
| +89% | +$13.2M | 0.36% | 69 |
|
|
2022
Q1 | $14.6M | Buy |
+60,361
| New | +$13.9M | 0.14% | 115 |
|
|
2017
Q1 | – | Sell |
-72,320
| Closed | -$10.6M | – | 396 |
|
|
2016
Q4 | $10.6M | Sell |
72,320
-25,342
| -26% | -$3.81M | 0.08% | 139 |
|
|
2016
Q3 | $16.3M | Sell |
97,662
-37,229
| -28% | -$6.3M | 0.12% | 121 |
|
|
2016
Q2 | $20.5M | Buy |
134,891
+15,250
| +13% | +$2.37M | 0.16% | 114 |
|
|
2016
Q1 | $17.9M | Buy |
119,641
+21,220
| +22% | +$3.15M | 0.13% | 121 |
|
|
2015
Q4 | $16M | Buy |
98,421
+31,943
| +48% | +$5.02M | 0.11% | 127 |
|
|
2015
Q3 | $9.2M | Buy |
66,478
+1,963
| +3% | +$309K | 0.07% | 143 |
|
|
2015
Q2 | $9.9M | Sell |
64,515
-163,026
| -72% | -$26.1M | 0.06% | 168 |
|
|
2015
Q1 | $36.4M | Buy |
227,541
+2,628
| +1% | +$414K | 0.17% | 127 |
|
|
2014
Q4 | $35.8M | Sell |
224,913
-162,470
| -42% | -$25.3M | 0.15% | 128 |
|
|
2014
Q3 | $54.4M | Sell |
387,383
-14,907
| -4% | -$1.95M | 0.22% | 117 |
|
|
2014
Q2 | $47.6M | Buy |
402,290
+26,850
| +7% | +$3.11M | 0.2% | 116 |
|
|
2014
Q1 | $46.3M | Buy |
375,440
+2,192
| +0.6% | +$266K | 0.19% | 109 |
|
|
2013
Q4 | $42.6M | Buy |
373,248
+950
| +0.3% | +$108K | 0.18% | 115 |
|
|
2013
Q3 | $41.7M | Buy |
372,298
+4,150
| +1% | +$450K | 0.19% | 105 |
|
|
2013
Q2 | $36.3M | Buy |
+368,148
| New | +$38.2M | 0.18% | 108 |
|
Other funds holding AMGN
VCM
VPM
TCW Group's AMGN Position: Q1 2026 in Review
TCW Group reduced its Amgen (AMGN) stake by 73% in Q1 2026, selling an estimated $24.4M and leaving 25,147 shares worth $8.85M. The position accounts for 0.07% of the portfolio, ranked #140.
TCW Group first reported a position in AMGN in Q2 2013 and has held it in 32 quarters since. The position peaked at $89.2M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- TCW Group held 25,147 shares of Amgen worth $8.85M as of Q1 2026.
- TCW Group sold 68,512 Amgen shares in Q1 2026, an estimated $24.4M.
- Amgen made up 0.07% of TCW Group's portfolio in Q1 2026, its #140 holding.
- TCW Group first reported a position in Amgen in Q2 2013 and has held it in 32 quarters since.
- TCW Group's Amgen position peaked at $89.2M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.